厄贝沙坦联合黄葵胶囊治疗慢性肾小球肾炎的效果观察

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the efficacy of Irbesartan combined with Huangkui Capsule in the treatment of chronic glomerulonephritis.MethodsFrom January 2016 to January 2017,40 patients with chronic glomerulonephritis treated in our hospital were selected as objects.According to the different therapeutic methods,they were divided into control group and observation group,20 cases in esch group.In the control group,patients were treated with Irbesartan only,while in the observation group,Huangkui Capsule was added.The clinical efficacy in the two groups was compared.ResultsBefore treatment,there was no significant difference in 24-hour proteinuria or serum creatinine(P＞0.05).After treatment,in the observation group[(0.82±0.24)g,(80.01±8.03)μmol/L]were lower than the observation group[(1.02±0.32)g,(83.52±10.11)μmol/L],and the differences were statistically significant(P＜0.05).After treatment,the 24-hour proteinuria and serum creatinine levels were lower than before treatment,and the differences were statistically significant(P＜0.05).The total effective treatment rate in the observation group (90.0%)was higher than that in the control group(70.0%),and the difference was statistically significant(P＜0.05).There was no significant difference in adverse reactions between the two groups (P＞0.05).ConclusionIrbesartan combined with Huangkui Capsule can obtain a great effect on treating chronic glomerulonephritis,which is worthy of clinical application and promotion.

Key words： Irbesartan HuangkuiCapsule Chronicglomerulonephritis Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIN Bi-hui
	YANG Li-hong

Cite this article:

JIN Bi-hui,YANG Li-hong. Effect observation of Irbesartan combined with Huangkui Capsule on treating chronic glomerulonephritis[J]. 中国当代医药, 2017, 24(30): 89-91.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I30/89

[1]	高利丽.黄葵胶囊联合厄贝沙坦治疗慢性肾小球肾炎的临床观察[J].中国中西医结合肾病杂志，2012，13（3）：236-237.
[2]	郭园园，杨辰华，张社峰.中医药治疗糖尿病肾病研究概况[J].中医研究，2016，29（10）：76-80.
[3]	毛文娟，王军升.黄葵胶囊联合替米沙坦治疗慢性肾脏病蛋白尿的临床观察[J].齐齐哈尔医学院学报，2012，33（18）：2478-2479.
[4]	龙悦.厄贝沙坦联合黄葵胶囊治疗慢性肾小球肾炎的临床效果观察[J].中国当代医药，2014，21（23）：85-86，89.
[5]	苏波峰，章慧娣.黄葵胶囊联合厄贝沙坦治疗IgA肾病的疗效观察[J].中国慢性病预防与控制，2014，22（5）：585-586.
[6]	樊映轩.黄葵花及其制剂（胶囊）对慢性肾炎治疗作用的研究进展[J].安徽医药，2014，18（12）：2393-2395.
[7]	姜健，沈沛成，王娴娴，等.从“虚”“ 瘀”“ 风”论治慢性肾炎研究进展[J].辽宁中医药大学学报，2017，19（8）：155-157.
[8]	岳玉和，王丽，刘文军.益气清热膏联合厄贝沙坦治疗慢性肾炎临床观察[J].湖北中医药大学学报，2016，18（2）：58-60.
[9]	宋增杰，曾佳丽，陈洪宇.黄蜀葵花治疗慢性肾脏病的药理作用研究进展[J].甘肃中医药大学学报，2016，33（2）：89-91.
[10]	刘红，孙伟，顾刘宝，等.黄葵胶囊联合ACEI或ARB类药物治疗糖尿病肾病的Meta分析[J].中华中医药杂志，2015，30（5）：1712-1718.
[11]	汤伟.缬沙坦联合金水宝治疗慢性肾炎蛋白尿临床研究[J].浙江中医药大学学报，2012，36（3）：287-289.
[12]	王光辉.坎地沙坦联合黄葵胶囊治疗慢性肾炎蛋白尿的临床疗效观察[J].现代诊断与治疗，2014，25（22）：5126-5127.
[13]	侯敬涛，汪翩，刘山.黄葵胶囊联合厄贝沙坦治疗慢性肾小球肾炎的临床分析[J].现代诊断与治疗，2015，26（4）：803-804.
[14]	谢帆，许陵冬，王跃娟，等.黄葵胶囊治疗糖尿病肾病临床应用[J].中医药临床杂志，2017，29（5）：610-613.
[15]	徐文君，吴国伟，郑卫华.黄葵胶囊联合厄贝沙坦治疗慢性肾小球肾炎临床观察[J].浙江中医杂志，2013，48（2）：153-154.
[16]	李霞，霍莲枝，尹学亮，等.黄葵胶囊联合厄贝沙坦对高血压肾损害患者尿蛋白和肾功能的影响[J].河南大学学报（医学版），2014，33（4）：277-279.